Opinion

Video

Advice for Patients with Advanced Renal Cell Carcinoma

Chandler H. Park, MD, discusses the role of support groups and outlines resources available to patients with kidney cancer.

Transcript:

Chandler H. Park, MD: One thing about kidney cancer is the strong support systems in place. We have kidney cancer support groups. And a lot of the leading cancer centers have patient support groups that meet monthly. We have care navigators. Something I highly encourage when you or a family member has a diagnosis of kidney cancer is talking to a local oncologist and asking about the local support groups. A lot of these local groups, I've been to a couple, are so warm and inviting. Patients diagnosed with kidney cancer discuss their experiences and treatment side effects. So, I would highly encourage everybody to talk to the cancer center that you live by and ask them for the kidney cancer support groups. They're in most of the major cities.

Transcript is AI-generated and edited for clarity and readability.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of man wearing baseball cap backwards.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of doctor with brown hair.
Image of man with black hair.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Related Content